[
  {
    "title": "AbbVie Inc. (ABBV): A Bull Case Theory",
    "link": "https://finance.yahoo.com/news/abbvie-inc-abbv-bull-case-185408984.html"
  },
  {
    "title": "The Zacks Analyst Blog Highlights Johnson & Johnson and AbbVie",
    "link": "https://finance.yahoo.com/news/zacks-analyst-blog-highlights-johnson-124800331.html"
  },
  {
    "title": "Trump Is Threatening Big Pharma With Tariffs. Tax Changes Might Work Better.",
    "link": "https://finance.yahoo.com/m/a4bec800-6f4b-30e9-8edf-e6305a9166c4/trump-is-threatening-big.html"
  },
  {
    "title": "If You Invested $10K In AbbVie Stock 10 Years Ago, How Much Would You Have Now?",
    "link": "https://finance.yahoo.com/news/invested-10k-abbvie-stock-10-021343505.html"
  },
  {
    "title": "JNJ vs. ABBV: Which Pharma Powerhouse Has Better Growth Prospects?",
    "link": "https://finance.yahoo.com/news/jnj-vs-abbv-pharma-powerhouse-122600727.html"
  },
  {
    "title": "AbbVie to Present at the Bank of America Securities Healthcare Conference",
    "link": "https://finance.yahoo.com/news/abbvie-present-bank-america-securities-120000852.html"
  },
  {
    "title": "ChatGPT Stock Advice: AbbVie Inc. (ABBV) Among Top Stock Recommendations",
    "link": "https://finance.yahoo.com/news/chatgpt-stock-advice-abbvie-inc-092646464.html"
  },
  {
    "title": "On tariffs and pricing, Big Pharma CEOs are waiting out the storm while planning for the worst",
    "link": "https://finance.yahoo.com/news/tariffs-pricing-big-pharma-ceos-071000003.html"
  },
  {
    "title": "1 Mega-Cap Stock Worth Your Attention and 2 to Keep Off Your Radar",
    "link": "https://finance.yahoo.com/news/1-mega-cap-stock-worth-043650970.html"
  },
  {
    "title": "Is the Trump Administration About to Cause AbbVie, Eli Lilly, and Johnson & Johnson Stocks to Crash?",
    "link": "https://finance.yahoo.com/news/trump-administration-cause-abbvie-eli-084900783.html"
  },
  {
    "title": "AbbVie Stock: Using A Long-Term Leap Ratio Spread On This Pharma Giant",
    "link": "https://finance.yahoo.com/m/6582d1f5-344d-3dbe-a369-33c5e615391b/abbvie-stock-using-a.html"
  },
  {
    "title": "Transforming HR Leadership: Inside The Darla Moore School’s Standout MHR Program",
    "link": "https://finance.yahoo.com/news/transforming-hr-leadership-inside-darla-222918095.html"
  },
  {
    "title": "BOTOX® Cosmetic (onabotulinumtoxinA) Continues its Mission of Empowering Entrepreneurs Through \"The Confidence Project\"",
    "link": "https://finance.yahoo.com/news/botox-cosmetic-onabotulinumtoxina-continues-mission-210000588.html"
  },
  {
    "title": "High Growth Tech Stocks In The US Market April 2025",
    "link": "https://finance.yahoo.com/news/high-growth-tech-stocks-us-113757674.html"
  },
  {
    "title": "FDA approves AbbVie’s upadacitinib for giant cell arteritis",
    "link": "https://finance.yahoo.com/news/fda-approves-abbvie-upadacitinib-giant-112115641.html"
  },
  {
    "title": "Moderna (MRNA) Reports Earnings Tomorrow: What To Expect",
    "link": "https://finance.yahoo.com/news/moderna-mrna-reports-earnings-tomorrow-071639842.html"
  },
  {
    "title": "Amgen (AMGN) Reports Earnings Tomorrow: What To Expect",
    "link": "https://finance.yahoo.com/news/amgen-amgn-reports-earnings-tomorrow-071434156.html"
  },
  {
    "title": "Biogen Earnings: What To Look For From BIIB",
    "link": "https://finance.yahoo.com/news/biogen-earnings-look-biib-071429863.html"
  },
  {
    "title": "What To Expect From BioMarin Pharmaceutical’s (BMRN) Q1 Earnings",
    "link": "https://finance.yahoo.com/news/expect-biomarin-pharmaceutical-bmrn-q1-070457101.html"
  },
  {
    "title": "AbbVie (NYSE:ABBV) Receives FDA Approval For RINVOQ In Treating Giant Cell Arteritis",
    "link": "https://finance.yahoo.com/news/abbvie-nyse-abbv-receives-fda-180010182.html"
  },
  {
    "title": "AbbVie Inc. (ABBV) Is a Trending Stock: Facts to Know Before Betting on It",
    "link": "https://finance.yahoo.com/news/abbvie-inc-abbv-trending-stock-130015856.html"
  },
  {
    "title": "Why Investors Need to Take Advantage of These 2 Medical Stocks Now",
    "link": "https://finance.yahoo.com/news/why-investors-advantage-2-medical-130008397.html"
  },
  {
    "title": "RINVOQ® (upadacitinib) Receives U.S. FDA Approval for Giant Cell Arteritis (GCA)",
    "link": "https://finance.yahoo.com/news/rinvoq-upadacitinib-receives-u-fda-113000825.html"
  },
  {
    "title": "United Therapeutics (UTHR) To Report Earnings Tomorrow: Here Is What To Expect",
    "link": "https://finance.yahoo.com/news/united-therapeutics-uthr-report-earnings-071053455.html"
  },
  {
    "title": "Why AbbVie Stock Trounced the Market Today",
    "link": "https://finance.yahoo.com/news/why-abbvie-stock-trounced-market-230200583.html"
  },
  {
    "title": "S&P 500 Gains and Losses Today: AbbVie Stock Advances After Beat-and-Raise Earnings Report",
    "link": "https://finance.yahoo.com/news/p-500-gains-losses-today-210754152.html"
  },
  {
    "title": "AbbVie Stock Rises Despite Risks as Earnings Beat Forecasts",
    "link": "https://finance.yahoo.com/m/201e5306-0bab-38ea-b940-5b8a955e647a/abbvie-stock-rises-despite.html"
  },
  {
    "title": "ALX Oncology’s CD47-blocker and Keytruda combo fails in two Phase II trials",
    "link": "https://finance.yahoo.com/news/alx-oncology-cd47-blocker-keytruda-115113376.html"
  },
  {
    "title": "3 Dividend Stocks to Buy and Hold for the Next Decade",
    "link": "https://finance.yahoo.com/news/3-dividend-stocks-buy-hold-114700146.html"
  },
  {
    "title": "Company News for Apr 28, 2025",
    "link": "https://finance.yahoo.com/news/company-news-apr-28-2025-091800064.html"
  },
  {
    "title": "Should Investors Be Worried About Dividend King AbbVie?",
    "link": "https://finance.yahoo.com/news/investors-worried-dividend-king-abbvie-084200183.html"
  },
  {
    "title": "AbbVie Inc. (ABBV): Among Billionaire Ken Fisher’s Healthcare Stock Picks with Massive Upside Potential",
    "link": "https://finance.yahoo.com/news/abbvie-inc-abbv-among-billionaire-185806062.html"
  },
  {
    "title": "AbbVie First Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags",
    "link": "https://finance.yahoo.com/news/abbvie-first-quarter-2025-earnings-130959876.html"
  },
  {
    "title": "4 Surefire Dividend Stocks to Buy in the Stock Market Sell-Off",
    "link": "https://finance.yahoo.com/news/4-surefire-dividend-stocks-buy-220500399.html"
  },
  {
    "title": "China weighs U.S. tariff exemptions, Alphabet reports Q1 beat: Morning Buzz",
    "link": "https://finance.yahoo.com/news/china-weighs-u-tariff-exemptions-162055045.html"
  },
  {
    "title": "AbbVie Inc (ABBV) Q1 2025 Earnings Call Highlights: Strong Growth in Immunology and ...",
    "link": "https://finance.yahoo.com/news/abbvie-inc-abbv-q1-2025-070417775.html"
  },
  {
    "title": "Q1 2025 AbbVie Inc Earnings Call",
    "link": "https://finance.yahoo.com/news/q1-2025-abbvie-inc-earnings-051117804.html"
  },
  {
    "title": "How Much Would It Take To Earn $100 A Month From AbbVie Stock",
    "link": "https://finance.yahoo.com/news/much-earn-100-month-abbvie-020751320.html"
  },
  {
    "title": "Why AbbVie Stock Topped the Market Today",
    "link": "https://finance.yahoo.com/news/why-abbvie-stock-topped-market-211726279.html"
  },
  {
    "title": "Is AbbVie Inc. (ABBV) the Best Dividend Stock to Buy for Long-Term Passive Income?",
    "link": "https://finance.yahoo.com/news/abbvie-inc-abbv-best-dividend-203800837.html"
  },
  {
    "title": "AbbVie Hikes Its Outlook On The Back Of Two Powerhouse Drugs",
    "link": "https://finance.yahoo.com/m/848cdb1f-9f70-3f8e-aa8b-6ccaa0d8cc36/abbvie-hikes-its-outlook-on.html"
  },
  {
    "title": "Sector Update: Health Care Stocks Advance Late Afternoon",
    "link": "https://finance.yahoo.com/news/sector-health-care-stocks-advance-200240059.html"
  },
  {
    "title": "AbbVie (NYSE:ABBV) Reports US$13 Billion Sales, Submits Application For New Neurotoxin",
    "link": "https://finance.yahoo.com/news/abbvie-nyse-abbv-reports-us-175333452.html"
  },
  {
    "title": "AbbVie Beats on Q1 Earnings & Sales, Raises '25 EPS View",
    "link": "https://finance.yahoo.com/news/abbvie-beats-q1-earnings-sales-171800749.html"
  },
  {
    "title": "Bitcoin extends rally, AbbVie earnings beat, Phillips 66 miss",
    "link": "https://finance.yahoo.com/video/bitcoin-extends-rally-abbvie-earnings-171137424.html"
  },
  {
    "title": "AbbVie Stock Rises on Stronger-Than-Expected Results, Profit Outlook Lift",
    "link": "https://finance.yahoo.com/news/abbvie-stock-rises-stronger-expected-164926578.html"
  },
  {
    "title": "Drugmaker Abbvie Ramps Up Domestic Manufacturing Plans on Tariff Threats",
    "link": "https://finance.yahoo.com/m/d7874453-6ad3-37b3-95bb-68a2356b1dba/drugmaker-abbvie-ramps-up.html"
  },
  {
    "title": "AbbVie warns of tariff exposure, U.S. policy risks while boosting forecast",
    "link": "https://finance.yahoo.com/news/abbvie-warns-tariff-exposure-u-153353444.html"
  },
  {
    "title": "AbbVie Raises Full-Year Outlook as First-Quarter Results Top Street Estimates",
    "link": "https://finance.yahoo.com/news/abbvie-raises-full-outlook-first-144513452.html"
  },
  {
    "title": "AbbVie, Schlumberger, Colgate-Palmolive: Trending tickers",
    "link": "https://finance.yahoo.com/video/abbvie-schlumberger-colgate-palmolive-trending-135355138.html"
  },
  {
    "title": "AbbVie (ABBV) Reports Q1 Earnings: What Key Metrics Have to Say",
    "link": "https://finance.yahoo.com/news/abbvie-abbv-reports-q1-earnings-133014725.html"
  },
  {
    "title": "AbbVie (ABBV) Q1 Earnings and Revenues Beat Estimates",
    "link": "https://finance.yahoo.com/news/abbvie-abbv-q1-earnings-revenues-125502278.html"
  },
  {
    "title": "AbbVie Inc. (ABBV): One of the Growing Dividend Stocks with Low PE Ratios",
    "link": "https://finance.yahoo.com/news/abbvie-inc-abbv-one-growing-122149162.html"
  },
  {
    "title": "AbbVie (NYSE:ABBV) Reports Bullish Q1",
    "link": "https://finance.yahoo.com/news/abbvie-nyse-abbv-reports-bullish-121903305.html"
  },
  {
    "title": "AbbVie: Q1 Earnings Snapshot",
    "link": "https://finance.yahoo.com/news/abbvie-q1-earnings-snapshot-115209629.html"
  },
  {
    "title": "AbbVie lifts profit forecast, downplays tariff threat",
    "link": "https://finance.yahoo.com/news/abbvie-lifts-profit-forecast-strong-114737735.html"
  },
  {
    "title": "AbbVie Reports First-Quarter 2025 Financial Results",
    "link": "https://finance.yahoo.com/news/abbvie-reports-first-quarter-2025-114300471.html"
  },
  {
    "title": "Colgate-Palmolive earnings, consumer sentiment: What to Watch",
    "link": "https://finance.yahoo.com/video/colgate-palmolive-earnings-consumer-sentiment-230000839.html"
  },
  {
    "title": "AbbVie Submits Biologics License Application to U.S. FDA for TrenibotulinumtoxinE (TrenibotE) for the Treatment of Glabellar Lines",
    "link": "https://finance.yahoo.com/news/abbvie-submits-biologics-license-application-123000610.html"
  },
  {
    "title": "Merck (MRK) Q1 Earnings and Revenues Top Estimates",
    "link": "https://finance.yahoo.com/news/merck-mrk-q1-earnings-revenues-114007845.html"
  },
  {
    "title": "AbbVie (ABBV) Reports Earnings Tomorrow: What To Expect",
    "link": "https://finance.yahoo.com/news/abbvie-abbv-reports-earnings-tomorrow-070109220.html"
  },
  {
    "title": "Buy Stock in These Healthcare Leaders as Q1 Earnings Approach? ABBV, HCA",
    "link": "https://finance.yahoo.com/news/buy-stock-healthcare-leaders-q1-230800700.html"
  },
  {
    "title": "Why AbbVie Inc. (ABBV) is Among the Best Stocks That Will Always Grow",
    "link": "https://finance.yahoo.com/news/why-abbvie-inc-abbv-among-142017422.html"
  },
  {
    "title": "The Zacks Analyst Blog Highlights Gilead Sciences, Bristol Myers, Merck, AbbVie and Sanofi",
    "link": "https://finance.yahoo.com/news/zacks-analyst-blog-highlights-gilead-132500143.html"
  },
  {
    "title": "Buy, Sell or Hold ABBV Stock? Key Tips Ahead of Q1 Earnings",
    "link": "https://finance.yahoo.com/news/buy-sell-hold-abbv-stock-123400358.html"
  },
  {
    "title": "2 High-Yield Dividend Stocks to Buy for Passive Income",
    "link": "https://finance.yahoo.com/news/2-high-yield-dividend-stocks-123000741.html"
  },
  {
    "title": "Eli Lilly, Vertex, AbbVie, and More Pharma Stocks to Own as Tariffs Loom",
    "link": "https://finance.yahoo.com/m/c624f5c7-9427-3beb-9308-f1a701d24813/eli-lilly-vertex-abbvie-.html"
  },
  {
    "title": "Analysts Estimate Pfizer (PFE) to Report a Decline in Earnings: What to Look Out for",
    "link": "https://finance.yahoo.com/news/analysts-estimate-pfizer-pfe-report-140058650.html"
  },
  {
    "title": "Cantor initiates coverage of U.S. large-cap pharma stocks: Gilead, AbbVie at Buy",
    "link": "https://finance.yahoo.com/news/cantor-initiates-coverage-u-large-134801368.html"
  },
  {
    "title": "Seeking Clues to AbbVie (ABBV) Q1 Earnings? A Peek Into Wall Street Projections for Key Metrics",
    "link": "https://finance.yahoo.com/news/seeking-clues-abbvie-abbv-q1-131519527.html"
  },
  {
    "title": "Will These 5 Large Drug Maker Stocks Surpass Q1 Earnings Forecast?",
    "link": "https://finance.yahoo.com/news/5-large-drug-maker-stocks-130600789.html"
  },
  {
    "title": "Do Options Traders Know Something About AbbVie (ABBV) Stock We Don't?",
    "link": "https://finance.yahoo.com/news/options-traders-know-something-abbvie-123000258.html"
  },
  {
    "title": "AbbVie (ABBV) Stock Moves -1.64%: What You Should Know",
    "link": "https://finance.yahoo.com/news/abbvie-abbv-stock-moves-1-214533823.html"
  },
  {
    "title": "Jim Cramer Is Bullish on AbbVie Inc. (ABBV) Ahead of Earnings",
    "link": "https://finance.yahoo.com/news/jim-cramer-bullish-abbvie-inc-141550679.html"
  },
  {
    "title": "Is AbbVie Stock a Buy?",
    "link": "https://finance.yahoo.com/news/abbvie-stock-buy-121500596.html"
  },
  {
    "title": "Is AbbVie Inc. (ABBV) the Best Pharma Stock to Buy for Long Term Growth?",
    "link": "https://finance.yahoo.com/news/abbvie-inc-abbv-best-pharma-151344374.html"
  },
  {
    "title": "Is AbbVie Inc. (ABBV) the Best Large-Cap Value Stock to Buy as the Recession Hits?",
    "link": "https://finance.yahoo.com/news/abbvie-inc-abbv-best-large-140251498.html"
  },
  {
    "title": "AbbVie (ABBV) Earnings Expected to Grow: What to Know Ahead of Next Week's Release",
    "link": "https://finance.yahoo.com/news/abbvie-abbv-earnings-expected-grow-140017160.html"
  },
  {
    "title": "Stocks to watch this week: Tesla, Alphabet, Intel, Boeing and Unilever",
    "link": "https://finance.yahoo.com/news/tesla-alphabet-intel-boeing-unilever-stocks-to-watch-050026597.html"
  },
  {
    "title": "AbbVie Inc. (ABBV): Among the Innovative Healthcare Stocks to Watch in 2025",
    "link": "https://finance.yahoo.com/news/abbvie-inc-abbv-among-innovative-135020761.html"
  },
  {
    "title": "AbbVie Inc. (ABBV): One of the Best Dividend Monarchs to Invest in Now",
    "link": "https://finance.yahoo.com/news/abbvie-inc-abbv-one-best-152051129.html"
  },
  {
    "title": "Unpacking Q4 Earnings: AbbVie (NYSE:ABBV) In The Context Of Other Therapeutics Stocks",
    "link": "https://finance.yahoo.com/news/unpacking-q4-earnings-abbvie-nyse-090605646.html"
  },
  {
    "title": "The Zacks Analyst Blog AbbVie, The TJX, The Charles Schwab, Enzo Biochem and CVD Equipment",
    "link": "https://finance.yahoo.com/news/zacks-analyst-blog-abbvie-tjx-083300119.html"
  },
  {
    "title": "Top Research Reports for AbbVie, TJX & Charles Schwab",
    "link": "https://finance.yahoo.com/news/top-research-reports-abbvie-tjx-203000671.html"
  },
  {
    "title": "AbbVie Inc. (ABBV): One of the High Growth Forever Dividend Stocks to Invest In",
    "link": "https://finance.yahoo.com/news/abbvie-inc-abbv-one-high-114534597.html"
  },
  {
    "title": "The Zacks Analyst Blog Merck and AbbVie",
    "link": "https://finance.yahoo.com/news/zacks-analyst-blog-merck-abbvie-105400252.html"
  },
  {
    "title": "ABBV vs. MRK: Which Drug Giant is a Better Buy Now?",
    "link": "https://finance.yahoo.com/news/abbv-vs-mrk-drug-giant-143700084.html"
  },
  {
    "title": "The Zacks Analyst Blog AbbVie's, Rinvoq and AstraZeneca's and Novartis",
    "link": "https://finance.yahoo.com/news/zacks-analyst-blog-abbvies-rinvoq-061700677.html"
  },
  {
    "title": "Is AbbVie Inc. (ABBV) the Best Stock for 15 Years?",
    "link": "https://finance.yahoo.com/news/abbvie-inc-abbv-best-stock-213955811.html"
  },
  {
    "title": "Pharma Stock Roundup: EU Nod to Expanded Use of ABBV, AZN Drugs & More",
    "link": "https://finance.yahoo.com/news/pharma-stock-roundup-eu-nod-154700353.html"
  },
  {
    "title": "Here’s Why Clearbridge Growth Strategy Sold AbbVie (ABBV)",
    "link": "https://finance.yahoo.com/news/why-clearbridge-growth-strategy-sold-141618933.html"
  },
  {
    "title": "S&P, Dow Jones Pharma Names Rattled — Again — On Trump's Tariffs Whiplash",
    "link": "https://finance.yahoo.com/m/5788e167-ba2e-3f2d-8e9e-4bfb72e0e2c1/s-p-dow-jones-pharma-names.html"
  },
  {
    "title": "Investors Heavily Search AbbVie Inc. (ABBV): Here is What You Need to Know",
    "link": "https://finance.yahoo.com/news/investors-heavily-search-abbvie-inc-130016248.html"
  },
  {
    "title": "Dow Jones, S&P 500 Pharma Names Recover After Trump Backs Off His Tariffs Plan",
    "link": "https://finance.yahoo.com/m/be7d1b24-7c1e-38ff-91b2-281ea7807568/dow-jones-s-p-500-pharma.html"
  },
  {
    "title": "Novo Nordisk, AbbVie Stocks Slide After Trump Vows Pharma Tariffs",
    "link": "https://finance.yahoo.com/m/f171bfb7-94e2-3b98-bde2-9d5add357a5c/novo-nordisk-abbvie-stocks.html"
  },
  {
    "title": "2 Top Dividend Stocks That Could Set You Up for Life",
    "link": "https://finance.yahoo.com/news/2-top-dividend-stocks-could-110000186.html"
  },
  {
    "title": "AbbVie’s upadacitinib gains EU marketing authorisation for GCA",
    "link": "https://finance.yahoo.com/news/abbvie-upadacitinib-gains-eu-marketing-090148754.html"
  },
  {
    "title": "AbbVie's Rinvoq Gets EU Nod for 8th Indication Giant Cell Arteritis",
    "link": "https://finance.yahoo.com/news/abbvies-rinvoq-gets-eu-nod-131500800.html"
  },
  {
    "title": "Goldman turns cautious on major pharma names, sees select upside at Eli Lilly",
    "link": "https://finance.yahoo.com/news/goldman-turns-cautious-major-pharma-130817424.html"
  },
  {
    "title": "Should Schwab U.S. Dividend Equity ETF (SCHD) Be on Your Investing Radar?",
    "link": "https://finance.yahoo.com/news/schwab-u-dividend-equity-etf-102008338.html"
  },
  {
    "title": "AbbVie Announces European Commission Approval of RINVOQ® (upadacitinib) for the Treatment of Adults with Giant Cell Arteritis",
    "link": "https://finance.yahoo.com/news/abbvie-announces-european-commission-approval-060000872.html"
  },
  {
    "title": "AbbVie (NYSE:ABBV) Showcases Cancer Treatment Advancements at AACR Annual Meeting",
    "link": "https://finance.yahoo.com/news/abbvie-nyse-abbv-showcases-cancer-173157102.html"
  },
  {
    "title": "China announces retaliatory tariffs, U.S. unemployment rises: Morning Buzz",
    "link": "https://finance.yahoo.com/news/china-announces-retaliatory-tariffs-u-161032836.html"
  },
  {
    "title": "2 Dividend Stocks to Buy Hand Over Fist in April",
    "link": "https://finance.yahoo.com/news/2-dividend-stocks-buy-hand-123000661.html"
  },
  {
    "title": "AbbVie (ABBV) Stock Moves -1.73%: What You Should Know",
    "link": "https://finance.yahoo.com/news/abbvie-abbv-stock-moves-1-214515437.html"
  },
  {
    "title": "AbbVie cuts 2025 profit forecast on acquisition expenses",
    "link": "https://finance.yahoo.com/news/abbvie-cuts-2025-profit-forecast-203448175.html"
  },
  {
    "title": "3 High-Yielding Dividend Stocks That Retirees Can Buy and Forget About",
    "link": "https://finance.yahoo.com/news/3-high-yielding-dividend-stocks-130000935.html"
  },
  {
    "title": "AbbVie Stock Rises 16% Year to Date: Time to Buy, Sell or Hold?",
    "link": "https://finance.yahoo.com/news/abbvie-stock-rises-16-date-140600657.html"
  },
  {
    "title": "High Growth Tech Stocks To Watch In The US April 2025",
    "link": "https://finance.yahoo.com/news/high-growth-tech-stocks-watch-110804833.html"
  },
  {
    "title": "MTVA: Phase 1 Part 2 Data for DA-1726 in Obesity Expected Soon…",
    "link": "https://finance.yahoo.com/news/mtva-phase-1-part-2-141600803.html"
  },
  {
    "title": "AbbVie to Host First-Quarter 2025 Earnings Conference Call",
    "link": "https://finance.yahoo.com/news/abbvie-host-first-quarter-2025-120000473.html"
  },
  {
    "title": "Want $1 Million in Retirement? 3 Stocks to Buy Now and Hold for Decades.",
    "link": "https://finance.yahoo.com/news/want-1-million-retirement-3-085300048.html"
  },
  {
    "title": "AbbVie Inc. (ABBV): Among the Best Dividend Aristocrat Stocks with Over 3% Yield",
    "link": "https://finance.yahoo.com/news/abbvie-inc-abbv-among-best-232508103.html"
  },
  {
    "title": "3 Relatively Safe Stocks to Buy Right Now",
    "link": "https://finance.yahoo.com/news/3-relatively-safe-stocks-buy-104500693.html"
  },
  {
    "title": "AbbVie Inc. (ABBV) is Attracting Investor Attention: Here is What You Should Know",
    "link": "https://finance.yahoo.com/news/abbvie-inc-abbv-attracting-investor-130016421.html"
  },
  {
    "title": "VKTX Finishes Enrolment in Mid-Stage Study on Oral Weight-Loss Drug",
    "link": "https://finance.yahoo.com/news/vktx-finishes-enrolment-mid-stage-123100379.html"
  },
  {
    "title": "CollPlant Biotechnologies Ltd (CLGN) Q4 2024 Earnings Call Highlights: Navigating Revenue ...",
    "link": "https://finance.yahoo.com/news/collplant-biotechnologies-ltd-clgn-q4-070159846.html"
  },
  {
    "title": "AbbVie (NYSE:ABBV) Showcases Oncology Innovations Amidst 6% Share Price Dip",
    "link": "https://finance.yahoo.com/news/abbvie-nyse-abbv-showcases-oncology-174606580.html"
  },
  {
    "title": "AbbVie Showcases Early Pipeline and Scientific Advances in Oncology at AACR Annual Meeting 2025",
    "link": "https://finance.yahoo.com/news/abbvie-showcases-early-pipeline-scientific-123000731.html"
  },
  {
    "title": "These Dividend Stocks Can Protect You From the Next Market Drop",
    "link": "https://finance.yahoo.com/m/7d333c75-ac96-3e68-aa51-35c647e66bec/these-dividend-stocks-can.html"
  },
  {
    "title": "2 Dividend Stocks Defying the Market Dip to Buy for a Lifetime of Passive Income",
    "link": "https://finance.yahoo.com/news/2-dividend-stocks-defying-market-103000309.html"
  },
  {
    "title": "S&P 500 Gains and Losses Today: International Paper Stock Pops on Upbeat Growth Outlook",
    "link": "https://finance.yahoo.com/news/p-500-gains-losses-today-211117025.html"
  },
  {
    "title": "3 Healthcare Stocks in the Doghouse",
    "link": "https://finance.yahoo.com/news/3-healthcare-stocks-doghouse-130141781.html"
  },
  {
    "title": "5 Large Drug Stocks to Watch as Industry Recovers",
    "link": "https://finance.yahoo.com/news/5-large-drug-stocks-watch-104700001.html"
  },
  {
    "title": "AbbVie (ABBV) Stock Sinks As Market Gains: Here's Why",
    "link": "https://finance.yahoo.com/news/abbvie-abbv-stock-sinks-market-214514704.html"
  },
  {
    "title": "Q4 Rundown: Moderna (NASDAQ:MRNA) Vs Other Therapeutics Stocks",
    "link": "https://finance.yahoo.com/news/q4-rundown-moderna-nasdaq-mrna-090109783.html"
  },
  {
    "title": "Allergan Aesthetics Emphasizes Commitment to Innovation, Science and a Patient Centric Approach at AMWC 2025",
    "link": "https://finance.yahoo.com/news/allergan-aesthetics-emphasizes-commitment-innovation-080200727.html"
  },
  {
    "title": "Is AbbVie Inc. (ABBV) The Best Healthcare Dividend Stock to Invest in?",
    "link": "https://finance.yahoo.com/news/abbvie-inc-abbv-best-healthcare-175556036.html"
  },
  {
    "title": "J&J's Tremfya Gets FDA Nod for 2nd IBD Condition Crohn's Disease",
    "link": "https://finance.yahoo.com/news/j-js-tremfya-gets-fda-122800316.html"
  },
  {
    "title": "Here's How Many Shares of AbbVie You Need to Own to Get $1,000 in Yearly Dividends",
    "link": "https://finance.yahoo.com/news/heres-many-shares-abbvie-own-133100580.html"
  },
  {
    "title": "3 Dividend Stocks to Buy for Reliable Passive Income",
    "link": "https://finance.yahoo.com/news/3-dividend-stocks-buy-reliable-113000637.html"
  },
  {
    "title": "AbbVie (ABBV) Stock Moves -0.29%: What You Should Know",
    "link": "https://finance.yahoo.com/news/abbvie-abbv-stock-moves-0-214516253.html"
  },
  {
    "title": "AbbVie upgraded to Buy at Erste Group on Friday",
    "link": "https://finance.yahoo.com/news/abbvie-upgraded-buy-erste-group-132007198.html"
  },
  {
    "title": "AbbVie reports final analysis from Phase III trial of Elahere for ovarian cancer",
    "link": "https://finance.yahoo.com/news/abbvie-reports-final-analysis-phase-102631064.html"
  },
  {
    "title": "The Zacks Analyst Blog Highlights AbbVie, Lockheed Martin, Dell and Hamilton Beach Brands",
    "link": "https://finance.yahoo.com/news/zacks-analyst-blog-highlights-abbvie-100600161.html"
  },
  {
    "title": "1 No-Brainer High-Yield Dividend ETF to Buy During the Stock Market Correction",
    "link": "https://finance.yahoo.com/news/1-no-brainer-high-yield-221900134.html"
  },
  {
    "title": "AbbVie (NYSE:ABBV) Reports ELAHERE Success in Phase 3 Trials for Platinum-Resistant Ovarian Cancer",
    "link": "https://finance.yahoo.com/news/abbvie-nyse-abbv-reports-elahere-171649465.html"
  },
  {
    "title": "ELAHERE® (mirvetuximab soravtansine-gynx) Shows Consistent Survival Benefit in Long-Term Analysis for Certain Ovarian Cancer Patients",
    "link": "https://finance.yahoo.com/news/elahere-mirvetuximab-soravtansine-gynx-shows-120000918.html"
  },
  {
    "title": "Top Analyst Reports for AbbVie, Lockheed Martin & Dell",
    "link": "https://finance.yahoo.com/news/top-analyst-reports-abbvie-lockheed-204700471.html"
  },
  {
    "title": "Q4 2024 Regenxbio Inc Earnings Call",
    "link": "https://finance.yahoo.com/news/q4-2024-regenxbio-inc-earnings-133904902.html"
  },
  {
    "title": "3 No-Brainer Healthcare Stocks to Buy With $1,000 Right Now",
    "link": "https://finance.yahoo.com/news/3-no-brainer-healthcare-stocks-095100770.html"
  },
  {
    "title": "Big Pharma Walked Away From Mental Health. Why Some Are Coming Back.",
    "link": "https://finance.yahoo.com/m/0697c71d-5603-3cea-bd4a-2f71f6c6cdaa/big-pharma-walked-away-from.html"
  },
  {
    "title": "Why AbbVie Inc. (ABBV) is the Best Pharma Stock to Buy According to Hedge Funds",
    "link": "https://finance.yahoo.com/news/why-abbvie-inc-abbv-best-183732966.html"
  },
  {
    "title": "Roche signs $5.3 billion deal with Danish obesity drugmaker, Novo Nordisk stock slides 4%",
    "link": "https://finance.yahoo.com/news/roche-signs-53-billion-deal-with-danish-obesity-drugmaker-novo-nordisk-stock-slides-4-160223732.html"
  },
  {
    "title": "VKTX Inks Manufacturing Deal With CordenPharma for Obesity Drug Supply",
    "link": "https://finance.yahoo.com/news/vktx-inks-manufacturing-deal-cordenpharma-121800284.html"
  },
  {
    "title": "Worried About a Market Meltdown? 2 Dividend Stocks to Own Forever.",
    "link": "https://finance.yahoo.com/news/worried-market-meltdown-2-dividend-111000567.html"
  },
  {
    "title": "Why AbbVie (ABBV) Dipped More Than Broader Market Today",
    "link": "https://finance.yahoo.com/news/why-abbvie-abbv-dipped-more-214516148.html"
  },
  {
    "title": "AbbVie (NYSE:ABBV) Urges Shareholders To Reject Proposals On Voting Rules And Human Rights Due Diligence",
    "link": "https://finance.yahoo.com/news/abbvie-nyse-abbv-urges-shareholders-181317397.html"
  },
  {
    "title": "Winners And Losers Of Q4: Myriad Genetics (NASDAQ:MYGN) Vs The Rest Of The Therapeutics Stocks",
    "link": "https://finance.yahoo.com/news/winners-losers-q4-myriad-genetics-090310721.html"
  },
  {
    "title": "AbbVie Inc. (ABBV): A Magnificent Dividend Growth Stock to Invest In",
    "link": "https://finance.yahoo.com/news/abbvie-inc-abbv-magnificent-dividend-083738499.html"
  },
  {
    "title": "Protagonist Therapeutics Unveils 'Paradigm-Shifting' Drug And Breaks Out",
    "link": "https://finance.yahoo.com/m/c61042d3-aaf8-3429-b052-5ed6faa64f92/protagonist-therapeutics.html"
  },
  {
    "title": "Is AbbVie Inc. (ABBV) the Best Performing Dividend Stock to Buy Now?",
    "link": "https://finance.yahoo.com/news/abbvie-inc-abbv-best-performing-194036728.html"
  },
  {
    "title": "Zacks Market Edge Highlights: Berkshire Hathaway, Aon plc and AbbVie",
    "link": "https://finance.yahoo.com/news/zacks-market-edge-highlights-berkshire-144700736.html"
  },
  {
    "title": "This Top Dividend Stock Just Entered The Weight Loss Market: Is It a Buy?",
    "link": "https://finance.yahoo.com/news/top-dividend-stock-just-entered-115700730.html"
  },
  {
    "title": "AbbVie Inc. (ABBV): Among The Stocks With At Least $10 Million In Insider Sales Recently",
    "link": "https://finance.yahoo.com/news/abbvie-inc-abbv-among-stocks-014631146.html"
  },
  {
    "title": "3 Stocks Breaking Out Right Now",
    "link": "https://finance.yahoo.com/news/3-stocks-breaking-now-165500094.html"
  },
  {
    "title": "Is Bayer (BAYRY) Outperforming Other Medical Stocks This Year?",
    "link": "https://finance.yahoo.com/news/bayer-bayry-outperforming-other-medical-144005468.html"
  },
  {
    "title": "Pharma Stock Roundup: BAYRY's Q4 Results, ABBV's Obesity Deal & More",
    "link": "https://finance.yahoo.com/news/pharma-stock-roundup-bayrys-q4-130900621.html"
  },
  {
    "title": "3 Cheap Stocks to Buy With Your Tax Refund Check",
    "link": "https://finance.yahoo.com/news/3-cheap-stocks-buy-tax-103000007.html"
  },
  {
    "title": "2 Dividend Stocks to Buy for a Lifetime of Passive Income",
    "link": "https://finance.yahoo.com/news/2-dividend-stocks-buy-lifetime-100300458.html"
  },
  {
    "title": "Johnson & Johnson and 4 Other Biopharmaceutical Stocks That Might Be Ready to Break Out",
    "link": "https://finance.yahoo.com/m/32d0d7c8-0bd1-33f4-8155-c5cc92624c9b/johnson-johnson-and-4-other.html"
  },
  {
    "title": "AbbVie (NYSE:ABBV) Expands SKYRIZI Availability In Canada For Ulcerative Colitis Treatment",
    "link": "https://finance.yahoo.com/news/abbvie-nyse-abbv-expands-skyrizi-175449614.html"
  },
  {
    "title": "Here's How to Play AbbVie Stock as it Enters the Obesity Space",
    "link": "https://finance.yahoo.com/news/heres-play-abbvie-stock-enters-133800732.html"
  },
  {
    "title": "Ariel Global Fund Added AbbVie (ABBV) on Dip",
    "link": "https://finance.yahoo.com/news/ariel-global-fund-added-abbvie-131928083.html"
  },
  {
    "title": "AbbVie to Present at the Leerink Partners Global Healthcare Conference",
    "link": "https://finance.yahoo.com/news/abbvie-present-leerink-partners-global-130000882.html"
  },
  {
    "title": "SKYRIZI® (risankizumab) Now Available for Moderately to Severely Active Ulcerative Colitis, Expanding AbbVie's Portfolio Across Inflammatory Bowel Disease",
    "link": "https://finance.yahoo.com/news/skyrizi-risankizumab-now-available-moderately-130000496.html"
  },
  {
    "title": "Spotting Winners: Sarepta Therapeutics (NASDAQ:SRPT) And Therapeutics Stocks In Q4",
    "link": "https://finance.yahoo.com/news/spotting-winners-sarepta-therapeutics-nasdaq-090319240.html"
  },
  {
    "title": "AbbVie Inc. (ABBV): Among the Best S&P 500 Dividend Stocks to Buy Now",
    "link": "https://finance.yahoo.com/news/abbvie-inc-abbv-among-best-085212886.html"
  },
  {
    "title": "AbbVie (ABBV) Rises As Market Takes a Dip: Key Facts",
    "link": "https://finance.yahoo.com/news/abbvie-abbv-rises-market-takes-224510578.html"
  },
  {
    "title": "AbbVie Enters The Obesity Arena. Why It's Paying Up To $2.23 Billion.",
    "link": "https://finance.yahoo.com/m/416b750b-695c-395e-89df-0e83c07d5880/abbvie-enters-the-obesity.html"
  },
  {
    "title": "AbbVie enters obesity treatment via Gubra licensing agreement",
    "link": "https://finance.yahoo.com/video/abbvie-enters-obesity-treatment-via-204954482.html"
  },
  {
    "title": "AbbVie Joins Obesity Treatment Market With Up to $2.2B Licensing Deal",
    "link": "https://finance.yahoo.com/news/abbvie-joins-obesity-treatment-market-184617825.html"
  },
  {
    "title": "AbbVie, Reddit, Allegro MicroSystems: Market Minute",
    "link": "https://finance.yahoo.com/video/abbvie-reddit-allegro-microsystems-market-181542556.html"
  },
  {
    "title": "AbbVie Enters Obesity Market Through Licensing Deal With Denmark's Gubra",
    "link": "https://finance.yahoo.com/news/abbvie-enters-obesity-market-licensing-152737328.html"
  },
  {
    "title": "ABBV Enters Obesity Bandwagon, Inks $2.2B Licensing Deal for Amylin Drug",
    "link": "https://finance.yahoo.com/news/abbv-enters-obesity-bandwagon-inks-135900599.html"
  },
  {
    "title": "AbbVie enters obesity space with $2.3bn Gubra deal",
    "link": "https://finance.yahoo.com/news/abbvie-enters-obesity-space-2-125201519.html"
  },
  {
    "title": "AbbVie gets into obesity with $350M deal for once-weekly shot",
    "link": "https://finance.yahoo.com/news/abbvie-gets-obesity-350m-deal-114953545.html"
  },
  {
    "title": "AbbVie and Gubra Announce License Agreement to Develop an Amylin Analog for the Treatment of Obesity",
    "link": "https://finance.yahoo.com/news/abbvie-gubra-announce-license-agreement-061100767.html"
  },
  {
    "title": "Is Ironwood Pharmaceuticals, Inc. (IRWD) the Best Small Cap Pharma Stock to Buy Now?",
    "link": "https://finance.yahoo.com/news/ironwood-pharmaceuticals-inc-irwd-best-172434518.html"
  },
  {
    "title": "Insiders At AbbVie Sold US$23m In Stock, Alluding To Potential Weakness",
    "link": "https://finance.yahoo.com/news/insiders-abbvie-sold-us-23m-110030526.html"
  },
  {
    "title": "AbbVie Inc. (ABBV): Among the Best Psychedelic Stocks to Buy in 2025",
    "link": "https://finance.yahoo.com/news/abbvie-inc-abbv-among-best-203059790.html"
  },
  {
    "title": "AbbVie's Next Big Moneymaker? This Drug Just Took a Huge Step Toward Approval",
    "link": "https://finance.yahoo.com/news/abbvies-next-big-moneymaker-drug-193244203.html"
  },
  {
    "title": "IRWD's Q4 Earnings and Revenues Fall Shy of Estimates, Stock Down",
    "link": "https://finance.yahoo.com/news/irwds-q4-earnings-revenues-fall-164300542.html"
  },
  {
    "title": "CHMP recommends AbbVie’s Rinvoq be approved for adult GCA",
    "link": "https://finance.yahoo.com/news/chmp-recommends-abbvie-rinvoq-approved-153905812.html"
  },
  {
    "title": "Drug Stocks Are the New Safe Bet in a Shaky Market",
    "link": "https://finance.yahoo.com/m/c6f9c271-5c7a-38f9-9f1a-5c020646702d/drug-stocks-are-the-new-safe.html"
  },
  {
    "title": "3 Reasons ABBV is Risky and 1 Stock to Buy Instead",
    "link": "https://finance.yahoo.com/news/3-reasons-abbv-risky-1-090722642.html"
  },
  {
    "title": "AbbVie Receives Positive CHMP Opinion for Upadacitinib (RINVOQ®) for the Treatment of Adults with Giant Cell Arteritis",
    "link": "https://finance.yahoo.com/news/abbvie-receives-positive-chmp-opinion-070000671.html"
  },
  {
    "title": "AbCellera Biologics (ABCL) Q4 2024 Earnings Call Transcript",
    "link": "https://finance.yahoo.com/news/abcellera-biologics-abcl-q4-2024-031512354.html"
  },
  {
    "title": "Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever",
    "link": "https://finance.yahoo.com/news/want-decades-passive-income-3-104700692.html"
  },
  {
    "title": "High Growth Tech Stocks To Watch In February 2025",
    "link": "https://finance.yahoo.com/news/high-growth-tech-stocks-watch-140209024.html"
  },
  {
    "title": "AbbVie to Present at the TD Cowen's 45th Annual Health Care Conference",
    "link": "https://finance.yahoo.com/news/abbvie-present-td-cowens-45th-130000625.html"
  },
  {
    "title": "Is AbbVie Inc. (ABBV) the Best DRIP Stock to Own Now?",
    "link": "https://finance.yahoo.com/news/abbvie-inc-abbv-best-drip-144156152.html"
  },
  {
    "title": "Sionna Therapeutics’ IPO: A strategic shift in the cystic fibrosis market",
    "link": "https://finance.yahoo.com/news/sionna-therapeutics-ipo-strategic-shift-105651362.html"
  },
  {
    "title": "AbbVie Inc. (ABBV): Among S&P 500 Dividend Aristocrats List",
    "link": "https://finance.yahoo.com/news/abbvie-inc-abbv-among-p-141458395.html"
  },
  {
    "title": "The Zacks Analyst Blog Highlights AbbVie, Amgen, Stryker, Dexcom and Medtronic",
    "link": "https://finance.yahoo.com/news/zacks-analyst-blog-highlights-abbvie-091700389.html"
  },
  {
    "title": "2 High-Yield Dividend ETFs to Buy to Generate Passive Income",
    "link": "https://finance.yahoo.com/news/2-high-yield-dividend-etfs-120000922.html"
  },
  {
    "title": "4 Seniors & Aging Demographics Stocks to Watch Right Now",
    "link": "https://finance.yahoo.com/news/4-seniors-aging-demographics-stocks-160600452.html"
  },
  {
    "title": "Some May Be Optimistic About AbbVie's (NYSE:ABBV) Earnings",
    "link": "https://finance.yahoo.com/news/may-optimistic-abbvies-nyse-abbv-103847100.html"
  },
  {
    "title": "2 Magnificent Dividend Growth Stocks to Load Up On Right Now",
    "link": "https://finance.yahoo.com/news/2-magnificent-dividend-growth-stocks-103000894.html"
  },
  {
    "title": "Bausch and Lomb's dealmaking CEO Brent Saunders: No deal for company is imminent",
    "link": "https://finance.yahoo.com/news/bausch-and-lombs-dealmaking-ceo-brent-saunders-no-deal-for-company-is-imminent-135301809.html"
  }
]